Luken Investment Analytics’s Pfizer PFE Stock Holding History

Luken Investment Analytics’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Hold	30,850	–	–	0.26%	40
2026 Q1	$866K	Sell	30,850 -2,798	-8%	-$74.5K	0.33%	35
2025 Q4	$838K	Buy	33,648 +35	+0.1%	+$883	0.33%	31
2025 Q3	$856K	Hold	33,613	–	–	0.33%	31
2025 Q2	$815K	Hold	33,613	–	–	0.36%	31
2025 Q1	$852K	Hold	33,613	–	–	0.4%	29
2024 Q4	$892K	Hold	33,613	–	–	0.41%	27
2024 Q3	$973K	Hold	33,613	–	–	0.45%	24
2024 Q2	$940K	Hold	33,613	–	–	0.47%	25
2024 Q1	$933K	Hold	33,613	–	–	0.47%	26
2023 Q4	$968K	Hold	33,613	–	–	0.52%	25
2023 Q3	$1.11M	Sell	33,613 -237	-0.7%	-$8.38K	0.65%	20
2023 Q2	$1.24M	Buy	33,850 +237	+0.7%	+$9.22K	0.69%	16
2023 Q1	$1.37M	Hold	33,613	–	–	0.81%	16
2022 Q4	$1.72M	Buy	+33,613	New	+$1.61M	1.1%	16
2020 Q4	$1.24M	Buy	+33,613	New	+$1.23M	0.92%	16

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Luken Investment Analytics's PFE Position: Q2 2026 in Review

Luken Investment Analytics held its Pfizer (PFE) position steady in Q2 2026 at 30,850 shares worth $743K. The position accounts for 0.26% of the portfolio, ranked #40.

Luken Investment Analytics first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.72M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Luken Investment Analytics held 30,850 shares of Pfizer worth $743K as of Q2 2026.
Luken Investment Analytics left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.26% of Luken Investment Analytics's portfolio in Q2 2026, its #40 holding.
Luken Investment Analytics first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
Luken Investment Analytics's Pfizer position peaked at $1.72M in Q4 2022.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.